CoraLite® Plus 488-conjugated SELPLG/CD162 Recombinant antibody

SELPLG/CD162 Uni-rAbTM Recombinant Antibody for IF/ICC
Cat No. CL488-84500

产品说明书

CloneNo. 241297G10

宿主/亚型

Rabbit / IgG

种属反应性

human

应用

IF/ICC

SELPLG, PSGL1, PSGL 1, P-selectin glycoprotein ligand 1, CLA

缓冲液配方:  PBS and Azide
PBS and Azide
偶联物:  CoraLite® Plus 488
规格: 

-/ -


经过测试的应用

Positive IF/ICC detected inJurkat cells
For other applications, we recommend the unconjugated version of this antibody, 84500-1-PBS

推荐稀释比

应用推荐稀释比
Immunofluorescence (IF)/ICCIF/ICC : 1:50-1:500
It is recommended that this reagent should be titrated in each testing system to obtain optimal results.
Sample-dependent, Check data in validation data gallery.

产品信息

CL488-84500 targets SELPLG/CD162 in IF/ICC applications and shows reactivity with human samples.

经测试应用 IF/ICC Application Description
经测试反应性 human
免疫原 Recombinant Protein 种属同源性预测
宿主/亚型 Rabbit / IgG
抗体类别 Recombinant
产品类型 Antibody
全称 selectin P ligand
别名 SELPLG, PSGL1, PSGL 1, P-selectin glycoprotein ligand 1, CLA
计算分子量 412 aa, 43 kDa
GenBank蛋白编号BC029782
基因名称 SELPLG
Gene ID (NCBI) 6404
偶联类型 CoraLite® Plus 488 Fluorescent Dye
最大激发/发射波长493 nm / 522 nm
形式 Liquid
纯化方式Protein A purification
UNIPROT IDQ14242
储存缓冲液 PBS with 50% glycerol, 0.05% Proclin300, 0.5% BSA , pH 7.3
储存条件Store at -20°C. Avoid exposure to light. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage.

背景介绍

SELPLG (selectin P ligand), also known as CD162 or PSGL-1, is a 120 kDa type I transmembrane mucin-like glycoprotein. It is an adhesion molecule expressed on the surface of neutrophils, monocytes, and most lymphocytes as a homodimer of approximately 230-250 kDa (PMID: 7545173; 1378449; 9353350). SELPLG plays a critical role in the early stages of inflammation due to its ability to bind E-selectin (CD62E), L-selectin (CD62L), and P-selectin (CD62P) (PMID: 35597982).

实验方案

Product Specific Protocols
IF protocol for CL Plus 488 SELPLG/CD162 antibody CL488-84500Download protocol
Standard Protocols
Click here to view our Standard Protocols
Loading...